Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Technology Venture Capital Trust Plc LSE:OXT London Ordinary Share GB0006640204 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 35.00 23,700 01:00:00
Bid Price Offer Price High Price Low Price Open Price
25.00 45.00 35.00 35.00 35.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial -0.04 -0.70 2
Last Trade Time Trade Type Trade Size Trade Price Currency
14:44:05 O 23,700 26.34 GBX

Oxford Technology Ventur... (OXT) Latest News

More Oxford Technology Ventur... News
Oxford Technology Ventur... Takeover Rumours

Oxford Technology Ventur... (OXT) Share Charts

1 Year Oxford Technology Ventur... Chart

1 Year Oxford Technology Ventur... Chart

1 Month Oxford Technology Ventur... Chart

1 Month Oxford Technology Ventur... Chart

Intraday Oxford Technology Ventur... Chart

Intraday Oxford Technology Ventur... Chart

Oxford Technology Ventur... (OXT) Discussions and Chat

Oxford Technology Ventur... Forums and Chat

Date Time Title Posts
16/7/201911:43Oxford Technology VCT with Charts & News48
19/8/200514:35Oxford Technology3

Add a New Thread

Oxford Technology Ventur... (OXT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Oxford Technology Ventur... trades in real-time

Oxford Technology Ventur... (OXT) Top Chat Posts

Oxford Technology Ventur... Daily Update: Oxford Technology Venture Capital Trust Plc is listed in the General Financial sector of the London Stock Exchange with ticker OXT. The last closing price for Oxford Technology Ventur... was 35p.
Oxford Technology Venture Capital Trust Plc has a 4 week average price of 35p and a 12 week average price of 35p.
The 1 year high share price is 40p while the 1 year low share price is currently 35p.
There are currently 5,431,655 shares in issue and the average daily traded volume is 69,500 shares. The market capitalisation of Oxford Technology Venture Capital Trust Plc is £1,901,079.25.
127tolmers: SCANCELL COULD BE THE NEXT BIG BENEFICIARY OF THE SPATE OF LICENSING DEALS ....... Matthew Goodman in this week's Sunday Times suggests Scancell could be the next big beneficiary of the spate of licensing deals currently being struck in the super hot area of Cancer Immunotherapy: "There are likely to be further deals struck as the pharma giants strive to boost their exposure to this rapidly expanding market. Scancell, an AIM-listed company that is developing melanoma vaccines, is set to begin a search for a bigger partner to help fund late-stage trials of its treatments after publishing encouraging data last month. "We are looking at 2014 as the year we consummate a relationship or a deal to take this forward," said Richard Goodfellow, Scancell's joint chief executive. Most drug companies are also looking into how different immunotherapies could work in tandem with existing cancer treatments." Is this the trigger for the OXT price reversal?
Oxford Technology Ventur... share price data is direct from the London Stock Exchange
Your Recent History
Oxford Tec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191015 21:21:23